Shockwave Medical, Inc.

Equities

SWAV

US82489T1043

Medical Equipment, Supplies & Distribution

Real-time Estimate Cboe BZX 03:24:58 2024-02-26 pm EST 5-day change 1st Jan Change
262.2 USD +0.52% Intraday chart for Shockwave Medical, Inc. +1.11% +37.51%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
UBS Raises Price Target on ShockWave Medical to $250 From $228, Maintains Neutral Rating MT
Sector Update: Health Care Stocks Higher Late Afternoon MT
ShockWave Medical's Shares Rise After Q4 Revenue Beat MT
Piper Sandler Raises ShockWave Medical's Price Target to $290 From $275, Keeps Overweight Rating MT
Needham Adjusts Price Target on ShockWave Medical to $286 From $260, Keeps Buy Rating MT
Morgan Stanley Raises Price Target on ShockWave Medical to $285 From $223, Keeps Overweight Rating MT
ShockWave Medical Q4 EPS Decreases, Revenue Rises; Issues Guidance MT
Transcript : Shockwave Medical, Inc., Q4 2023 Earnings Call, Feb 15, 2024
Shockwave Medical, Inc. Provides Earnings Guidance for 2024 CI
Shockwave Medical, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 CI
Shockwave Medical Insider Sold Shares Worth $463,518, According to a Recent SEC Filing MT
Shockwave Medical Insider Sold Shares Worth $644,581, According to a Recent SEC Filing MT
Shockwave Medical Insider Sold Shares Worth $1,537,962, According to a Recent SEC Filing MT
Shockwave Medical Insider Sold Shares Worth $782,577, According to a Recent SEC Filing MT
Shockwave Medical Insider Sold Shares Worth $898,760, According to a Recent SEC Filing MT
Shockwave Medical Names Renee Gaeta Chief Financial Officer MT
Shockwave Medical, Inc. Appoints Renee Gaeta as Chief Financial Officer, Effective February 5, 2024 CI
Shockwave Medical Insider Sold Shares Worth $4,408,103, According to a Recent SEC Filing MT
Shockwave Medical Insider Sold Shares Worth $397,975, According to a Recent SEC Filing MT
Shockwave Medical to Seek Acquisition CI
Transcript : Shockwave Medical, Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-10-2024 07:30 AM
Shockwave Medical Insider Sold Shares Worth $2,000,500, According to a Recent SEC Filing MT
Shockwave Medical Insider Sold Shares Worth $770,000, According to a Recent SEC Filing MT
Morgan Stanley Cuts ShockWave Medical's Price Target to $223 From $284, Maintains Overweight Rating MT
Transcript : Shockwave Medical, Inc. Presents at Piper Sandler 35th Annual Healthcare Conference, Nov-29-2023 01:30 PM
Chart Shockwave Medical, Inc.
More charts
Shockwave Medical, Inc. is a medical device company. The Company is focused on development and commercialization of products intended to transform the way calcified cardiovascular disease is treated. It provides care for the treatment of calcified cardiovascular disease through its differentiated local delivery of sonic pressure waves, intravascular lithotripsy (IVL). Its Shockwave M5 IVL catheter and Shockwave M5+ IVL catheter are five-emitter catheters for use in its IVL System in medium-diameter vessels for the treatment of peripheral artery disease (PAD). Its Shockwave S4 IVL catheter is a four-emitter catheter for use in its IVL System in small-diameter vessels for the treatment of PAD. Its Shockwave L6 IVL catheter is a six-emitter catheter for use in its IVL System in large diameter vessels for the treatment of PAD. Its Shockwave C2 IVL catheter and Shockwave C2+ IVL catheter are two-emitter catheters for use in its IVL System for the treatment of coronary artery disease (CAD).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
11
Last Close Price
260.8 USD
Average target price
257.5 USD
Spread / Average Target
-1.26%
Consensus
  1. Stock
  2. Equities
  3. Stock Shockwave Medical, Inc. - Nasdaq
  4. News Shockwave Medical, Inc.
  5. ShockWave Medical Says New Data Show Similar Coronary Intravascular Lithotripsy Safety, Effectiveness in Women, Men
-40% Limited-time offer: Our subscriptions help you unlock the best investment opportunities.
SIGN UP NOW